Brian Curtis

PUTNAM, CT, USA – (May 22, 2012) – Foster Corporation, a leader in custom medical polymers, has added state-of-the-art extrusion compounding capacity for custom pre-colored polymers used in Class I medical applications. The new line is designed to optimize pigment dispersion of challenging colors and polymers, and maximize throughput necessary to reduce compounding costs. Foster’s new […]

King of Prussia, PA — Arkema Inc. has implemented a 12-month advance notice for product specification changes on all Pebax® SA 01 MED polymers in order to provide medical device manufacturers with the necessary time for regulatory assessment.  Previously, notifications of change for these polymers sold in the medical market were unrestricted, similar to grades sold

PUTNAM, CT, USA – (January 31, 2012) – Foster Delivery Science, a business unit for Foster Corporation, has added comprehensive in-house laboratory services to expedite the screening of early stage formulations, process development, and post-extrusion studies of solid dose drug delivery forms using hot melt extrusion.  As a contract research and manufacturing company that specializes in hot

Putnam, CT, USA – (September 8, 2011) – Foster Corporation, a PolyMedex Discovery Group company and leader in biomedical materials, has introduced custom extruded film and rod from drug/polymer blends for implant, patch and oral drug delivery applications.  Working with customer specified active pharmaceutical ingredients and a range of polymer formulations, including EVA, bioresorbable and water

Putnam, CT, USA – (August 10, 2011) – Foster Corporationannounces the addition of personnel to its Delivery Science business unit. These hires bring additional experience from the implant and pharmaceutical industry to support demand for the company’s emerging work in the development and manufacturing of drug/polymer blends for implant, patch and oral drug delivery applications. The

Putnam, CT, USA – (February 7, 2011) – Foster Corporation announces the opening of its Medical Plastics Innovation Center. The center provides comprehensive development services of advanced polymer formulations used in leading edge medical devices. It offers polymer compounding, molding and extrusion process evaluation, and material property testing. Foster’s Medical Plastics Innovation Center is located within

Putnam, CT, USA – (May 4, 2010) – Foster Corporation, a PolyMedex Discovery Group company and innovator in polymer technology for minimally invasive devices and drug delivery, announces the availability of custom colored medical grade polymers. Specifically formulated for precision catheter components, Foster custom polymers feature superior color accuracy and surface quality as compared to traditional

Putnam, CT, USA – (September 29, 2009) – Foster Corporation, a PolyMedex Discovery Group company, introduces a new radiopaque polymer enhancement technology that offers a superior value option for the medical device industry. Marketed under the name Foster Bismuth Subcarbonate, this new radiopaque filler offers superior quality that translates to improved performance at the extrusion step

Putnam, CT, USA – (February 8, 2010) – Foster Corporation, a PolyMedex Discovery Group company, announces the expansion of the NanoMed™ nanoparticle technology to include thermoplastic elastomers (TPE) formulations for the minimally invasive device market. These new formulations dramatically increase flexural modulus (stiffness) of polymers while maintaining flexibility resulting in increased push and torque performance for

Putnam, CT, USA – (November 6, 2009) – Foster Corporation, a PolyMedex Discovery Group company and a specialist in melt extrusion blending and forming of highly regulated materials including active pharmaceutical ingredients (APIs), recently announced a partnership with the University of Rhode Island’s College of Pharmacy to expand the company’s formulation and analytical testing capabilities. “This